GFAP and dementia: This suggests that these biomarkers’ associations with cognitive outcomes may not be confounded by socioeconomic status and reinforces the potential utility of these neurodegenerative markers, particularly GFAP and NfL, as key biomarkers in predicting cognitive decline and dementia across diverse populations.